Machine learning identifies two autophagy-related genes as markers of recurrence in colorectal cancer
- PMID: 33076720
- PMCID: PMC7780659
- DOI: 10.1177/0300060520958808
Machine learning identifies two autophagy-related genes as markers of recurrence in colorectal cancer
Abstract
Objective: Colorectal cancer (CRC) is the most common cancer worldwide. Patient outcomes following recurrence of CRC are very poor. Therefore, identifying the risk of CRC recurrence at an early stage would improve patient care. Accumulating evidence shows that autophagy plays an active role in tumorigenesis, recurrence, and metastasis.
Methods: We used machine learning algorithms and two regression models, univariable Cox proportion and least absolute shrinkage and selection operator (LASSO), to identify 26 autophagy-related genes (ARGs) related to CRC recurrence.
Results: By functional annotation, these ARGs were shown to be enriched in necroptosis and apoptosis pathways. Protein-protein interactions identified SQSTM1, CASP8, HSP80AB1, FADD, and MAPK9 as core genes in CRC autophagy. Of 26 ARGs, BAX and PARP1 were regarded as having the most significant predictive ability of CRC recurrence, with prediction accuracy of 71.1%.
Conclusion: These results shed light on prediction of CRC recurrence by ARGs. Stratification of patients into recurrence risk groups by testing ARGs would be a valuable tool for early detection of CRC recurrence.
Keywords: Colorectal cancer; autophagy; autophagy-related gene; machine learning; recurrence; regression.
Figures







Similar articles
-
Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer.Mol Oncol. 2017 Nov;11(11):1544-1560. doi: 10.1002/1878-0261.12117. Epub 2017 Sep 23. Mol Oncol. 2017. PMID: 28796930 Free PMC article.
-
FOLFOX treatment response prediction in metastatic or recurrent colorectal cancer patients via machine learning algorithms.Cancer Med. 2020 Feb;9(4):1419-1429. doi: 10.1002/cam4.2786. Epub 2020 Jan 1. Cancer Med. 2020. PMID: 31893575 Free PMC article.
-
Transcriptomic Profiling Reveals an Enhancer RNA Signature for Recurrence Prediction in Colorectal Cancer.Genes (Basel). 2023 Jan 3;14(1):137. doi: 10.3390/genes14010137. Genes (Basel). 2023. PMID: 36672877 Free PMC article.
-
New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets.Autophagy. 2017 May 4;13(5):781-819. doi: 10.1080/15548627.2017.1290751. Epub 2017 Feb 23. Autophagy. 2017. PMID: 28358273 Free PMC article. Review.
-
MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.World J Gastroenterol. 2018 Jul 21;24(27):2949-2973. doi: 10.3748/wjg.v24.i27.2949. World J Gastroenterol. 2018. PMID: 30038463 Free PMC article. Review.
Cited by
-
Autophagy and the Insulin-like Growth Factor (IGF) System in Colonic Cells: Implications for Colorectal Neoplasia.Int J Mol Sci. 2023 Feb 11;24(4):3665. doi: 10.3390/ijms24043665. Int J Mol Sci. 2023. PMID: 36835075 Free PMC article. Review.
-
Effectiveness of Artificial Intelligence Models in Predicting Lung Cancer Recurrence: A Gene Biomarker-Driven Review.Cancers (Basel). 2025 Jun 5;17(11):1892. doi: 10.3390/cancers17111892. Cancers (Basel). 2025. PMID: 40507370 Free PMC article. Review.
-
Clostridium butyricum Regulates the Inflammatory and Immunoregulatory Pathway Through NFKB1 in Colorectal Cancer Treatment.Probiotics Antimicrob Proteins. 2025 Apr 25. doi: 10.1007/s12602-025-10547-w. Online ahead of print. Probiotics Antimicrob Proteins. 2025. PMID: 40279041
-
Non-Canonical Programmed Cell Death in Colon Cancer.Cancers (Basel). 2022 Jul 7;14(14):3309. doi: 10.3390/cancers14143309. Cancers (Basel). 2022. PMID: 35884370 Free PMC article. Review.
References
-
- Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008; 9: 730–756. - PubMed
-
- Renehan AG, Malcomson L, Emsley R, et al. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol 2016; 17: 174–183. - PubMed
-
- Tie J, Semira C, Gibbs P. Circulating tumor DNA as a biomarker to guide therapy in post-operative locally advanced rectal cancer: the best option? Expert Rev Mol Diagn 2018; 18: 1–3. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous